{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:23Z","timestamp":1786628243375,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-026-01774-z","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:29:10Z","timestamp":1780918150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increasing burden of Clostridioides difficile infection in Spain: nationwide trends in hospitalisations, 2016\u20132023"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1744-1564","authenticated-orcid":false,"given":"Yolanda","family":"Ortega-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Molina-Cabrillana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-4630","authenticated-orcid":false,"given":"Marco Antonio","family":"Sempere-Alcocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-3151","authenticated-orcid":false,"given":"Rosa","family":"L\u00f3pez-Gigosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"23","key":"1774_CR1","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1001\/jama.2025.18089","volume":"334","author":"J Van Prehn","year":"2025","unstructured":"J Van Prehn EJ Kuijper ER Dubberke 2025 Recurrent Clostridioides difficile infections JAMA 334 23 2128 https:\/\/doi.org\/10.1001\/jama.2025.18089","journal-title":"JAMA"},{"issue":"1","key":"1774_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","volume":"21","author":"E Finn","year":"2021","unstructured":"E Finn FL Andersson M Madin-Warburton 2021 Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI BMC Infect Dis 21 1 456 https:\/\/doi.org\/10.1186\/s12879-021-06147-y","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1774_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08096-0","volume":"23","author":"P Feuerstadt","year":"2023","unstructured":"P Feuerstadt N Theriault G Tillotson 2023 The burden of CDI in the United States: a multifactorial challenge BMC Infect Dis 23 1 132https:\/\/doi.org\/10.1186\/s12879-023-08096-0","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1774_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"FC Lessa Y Mu WM Bamberg ZG Beldavs GK Dumyati JR Dunn 2015 Burden of Clostridium difficile infection in the United States N Engl J Med 372 9 825 834 https:\/\/doi.org\/10.1056\/NEJMoa1408913","journal-title":"N Engl J Med"},{"key":"1774_CR5","unstructured":"Centers for Disease Control and Prevention. 2023. Emerging Infections Program, Healthcare-Associated Infections Community Interface Surveillance Report, Clostridioidesdi cileinfection (CDI), 2021 [PDF \u2013 7 Pages]. Available at: https:\/\/www.cdc.gov\/hai\/eip\/pdf\/cdi \/2021-CDI-Report-H.pdf [PDF \u2013 7 Pages]."},{"key":"1774_CR6","doi-asserted-by":"publisher","first-page":"102878","DOI":"10.1016\/j.anaerobe.2024.102878","volume":"88","author":"FJ Angulo","year":"2024","unstructured":"FJ Angulo M Furtado E Gonzalez P Zhang PH Kelly JC Mo\u00efsi 2024 Incidence of public health surveillance-reported Clostridioides difficile infections in thirteen countries worldwide: a narrative review Anaerobe 88 102878 https:\/\/doi.org\/10.1016\/j.anaerobe.2024.102878","journal-title":"Anaerobe"},{"key":"1774_CR7","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2022\u20132023. [Internet]. LU: Publications Office; 2024 [cited 2024 Oct 30]. Available from: https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2900\/88011","DOI":"10.2900\/88011"},{"key":"1774_CR8","unstructured":"European Centre for Disease Prevention and Control. Clostridioidesdifficileinfections. In: ECDC. Annual epidemiological report for 2018\u22122020. Stockholm: ECDC; 2024."},{"issue":"1","key":"1774_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12879-024-09218-y","volume":"24","author":"A Tricotel","year":"2024","unstructured":"A Tricotel A Antunes A Wilk S Dombrowski H Rinta-Kokko FL Andersson 2024 Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015\u22122019: the RECUR Germany study BMC Infect Dis 24 1 357 https:\/\/doi.org\/10.1186\/s12879-024-09218-y","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1774_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0897190013499521","volume":"26","author":"DD DePestel","year":"2013","unstructured":"DD DePestel DM Aronoff 2013 Epidemiology of Clostridium difficile infection J Pharm Pract 26 5 464 475 https:\/\/doi.org\/10.1177\/0897190013499521","journal-title":"J Pharm Pract"},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2015.05.013","volume":"36","author":"A Asensio","year":"2015","unstructured":"A Asensio S Di Bella A Lo Vecchio S Grau WM Hart B Isidoro 2015 The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study Int J Infect Dis 36 31 38 https:\/\/doi.org\/10.1016\/j.ijid.2015.05.013 PubMed PMID: 26003403.","journal-title":"Int J Infect Dis"},{"issue":"Suppl 6","key":"1774_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12064","volume":"18","author":"E Bouza","year":"2012","unstructured":"E Bouza 2012 Consequences of Clostridium difficile infection: understanding the healthcare burden Clin Microbiol Infect 18 Suppl 6 5 12 https:\/\/doi.org\/10.1111\/1469-0691.12064 PubMed PMID: 23121549.","journal-title":"Clin Microbiol Infect"},{"key":"1774_CR13","volume-title":"Clostridioides(Clostridium)difficileinfections. Annual epidemiological report for 2016\u20132017","author":"European Centre for Disease Prevention and Control","year":"2022","unstructured":"European Centre for Disease Prevention and Control 2022 Clostridioides(Clostridium)difficileinfections. Annual epidemiological report for 2016\u20132017 ECDC Stockholm"},{"key":"1774_CR14","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. European Centre for Disease Prevention and Control. European Surveillance of Clostridioides (Clostridium)difficileinfections. Surveillance protocol version 2.4. Stockholm: ECDC; 2019. [Internet]. LU: Publications Office; 2019 [cited 2025 Dec 1]. Available from: https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2900\/60304","DOI":"10.2900\/60304"},{"key":"1774_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012r 9;61(9):157\u201362"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-42108-2_1","volume":"1435","author":"E Reigadas","year":"2024","unstructured":"E Reigadas S V\u00e1zquez-Cuesta E Bouza 2024 Economic burden of Clostridioides difficile infection in European countries Adv Exp Med Biol 1435 1 12 https:\/\/doi.org\/10.1007\/978-3-031-42108-2_1 PubMed PMID: 38175468.","journal-title":"Adv Exp Med Biol"},{"issue":"10325","key":"1774_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"CJL Murray KS Ikuta F Sharara L Swetschinski G Robles Aguilar A Gray 2022 Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis The Lancet 399 10325 629 655 https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"The Lancet"},{"key":"1774_CR18","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention (U.S.). Antibiotic resistance threats in the United States, 2019 [Internet]. Centers for Disease Control and Prevention (U.S.); 2019 Nov [cited 2025 Dec 3]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/82532https:\/\/doi.org\/10.15620\/cdc:82532","DOI":"10.15620\/cdc:82532"},{"issue":"10","key":"1774_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.cmi.2018.02.020","volume":"24","author":"S Tschudin-Sutter","year":"2018","unstructured":"S Tschudin-Sutter EJ Kuijper A Durovic MJGT Vehreschild F Barbut C Eckert 2018 Guidance document for prevention of Clostridium difficile infection in acute healthcare settings Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 24 10 1051 1054 https:\/\/doi.org\/10.1016\/j.cmi.2018.02.020 PubMed PMID: 29505879","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"3","key":"1774_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eimce.2021.04.008","volume":"40","author":"\u00c1 Asensio","year":"2022","unstructured":"\u00c1 Asensio A Vallejo-Plaza LM Parra R Ort\u00ed-Lucas I Salcedo A Ramos 2022 Epidemiology of Clostridioides difficile infection in hospitalized patients in Spain: An eight-year review (2012\u20132019) Enfermedades Infecc Microbiol Clin Engl Ed 40 3 125 130 https:\/\/doi.org\/10.1016\/j.eimce.2021.04.008 PubMed PMID: 35249672","journal-title":"Enfermedades Infecc Microbiol Clin Engl Ed"},{"issue":"1","key":"1774_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","volume":"21","author":"E Finn","year":"2021","unstructured":"E Finn FL Andersson M Madin-Warburton 2021 Burden of Clostridioides difficile infection (CDI)-a systematic review of the epidemiology of primary and recurrent CDI BMC Infect Dis 21 1 456","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1774_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4321\/S1135-57272013000100004","volume":"87","author":"\u00c1 Asensio","year":"2013","unstructured":"\u00c1 Asensio E Bouza S Grau D Rubio-Rodr\u00edguez C Rubio-Terr\u00e9s 2013 Cost of Clostridium difficile associated diarrhea in Spain Rev Esp Salud Publica 87 1 25 33 https:\/\/doi.org\/10.4321\/S1135-57272013000100004 PubMed PMID: 23748655","journal-title":"Rev Esp Salud Publica"},{"key":"1774_CR23","unstructured":"Real Decreto 69\/2015, de 6 de febrero, por el que se regula el Registro de Actividad de Atenci\u00f3n Sanitaria Especializada."},{"key":"1774_CR24","doi-asserted-by":"publisher","first-page":"102178","DOI":"10.1016\/j.anaerobe.2020.102178","volume":"62","author":"K Davies","year":"2020","unstructured":"K Davies G Davis F Barbut C Eckert N Petrosillo R Pisapia 2020 Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see? Anaerobe 62 102178 https:\/\/doi.org\/10.1016\/j.anaerobe.2020.102178","journal-title":"Anaerobe"},{"issue":"12","key":"1774_CR25","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10096-016-2746-1","volume":"35","author":"K Davies","year":"2016","unstructured":"K Davies G Davis F Barbut C Eckert N Petrosillo MH Wilcox 2016 Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID) Eur J Clin Microbiol Infect Dis 35 12 1949 1956 https:\/\/doi.org\/10.1007\/s10096-016-2746-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"1774_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eimc.2011.09.010","volume":"30","author":"A Asensio","year":"2012","unstructured":"A Asensio D Monge 2012 Epidemiolog\u00eda de la infecci\u00f3n por Clostridium difficile en Espa\u00f1a Enfermedades Infecc Microbiol Cl\u00ednica 30 6 333 337 https:\/\/doi.org\/10.1016\/j.eimc.2011.09.010","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"1774_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20477724.2025.2580606","volume":"26","author":"R Garcia-Carretero","year":"2025","unstructured":"R Garcia-Carretero O Vazquez-Gomez B Rodriguez-Maya M Rodriguez-Gonzalez O Barquero-Perez R Gil-Prieto 2025 Epidemiology, recurrence, and mortality in patients with Clostridioides difficile : a nationwide surveillance study (2016\u20132022) Pathog Glob Health 26 1 8 https:\/\/doi.org\/10.1080\/20477724.2025.2580606","journal-title":"Pathog Glob Health"},{"issue":"7","key":"1774_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"LC McDonald DN Gerding S Johnson JS Bakken KC Carroll SE Coffin 2018 Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clin Infect Dis 66 7 987 994 https:\/\/doi.org\/10.1093\/cid\/ciy149","journal-title":"Clin Infect Dis"},{"key":"1774_CR29","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. Laboratory procedures for diagnosis and typing of human Clostridium difficile infection. [Internet]. LU: Publications Office; 2018 [cited 2025 Dec 1]. Available from: https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2900\/04291","DOI":"10.2900\/04291"},{"issue":"2","key":"1774_CR30","first-page":"151","volume":"33","author":"E Bouza","year":"2020","unstructured":"E Bouza JM Aguado L Alcal\u00e1 B Almirante P Alonso-Fern\u00e1ndez M Borges 2020 Recommendations for the diagnosis and treatment of Clostridioides difficile infection: an official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR) Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter 33 2 151 175","journal-title":"Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter"},{"issue":"5","key":"1774_CR31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/microorganisms10051075","volume":"10","author":"N Sopena","year":"2022","unstructured":"N Sopena JH Wang-Wang I Casas L Mateu L Castell\u00e0 MJ Garc\u00eda-Quesada 2022 Impact of the introduction of a two-step laboratory diagnostic algorithm in the incidence and earlier diagnosis of Clostridioides difficile infection Microorganisms 10 5 1075 https:\/\/doi.org\/10.3390\/microorganisms10051075","journal-title":"Microorganisms"},{"issue":"7","key":"1774_CR32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmi.2019.10.023","volume":"26","author":"SC Lim","year":"2020","unstructured":"SC Lim DR Knight TV Riley 2020 Clostridium difficile and one health Clin Microbiol Infect 26 7 857 863 https:\/\/doi.org\/10.1016\/j.cmi.2019.10.023 PubMed PMID: 31682985.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1774_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"D Baur BP Gladstone F Burkert E Carrara F Foschi S D\u00f6bele 2017 Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis Lancet Infect Dis 17 9 990 1001 https:\/\/doi.org\/10.1016\/S1473-3099(17)30325-0","journal-title":"Lancet Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-026-01774-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01774-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01774-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:02:41Z","timestamp":1786626161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-026-01774-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1186\/s13756-026-01774-z","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u201cAt the time of data extraction from the RAE-CMBD, a confidentiality agreement was signed to ensure the protection of personal data. All data were fully anonymised prior to analysis, and no direct or indirect identification of patients, healthcare facilities, or reporting units was possible. The dataset did not contain any variables that could enable re-identification, and the researchers had no access to identifiable clinical records. The RAE-CMBD is a national administrative healthcare database managed by the Spanish Ministry of Health and regulated under Spanish legislation governing the use of administrative healthcare data for research and public health purposes. According to Regulation (EU) 2016\/679 and Organic Law 3\/2018 on the protection of personal data, fully anonymised data are not considered personal data. Therefore, studies based exclusively on such data do not require approval from a Research Ethics Committee. Accordingly, no ethics approval was required for this study.\u201d","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"102"}}